News

Milepoint: The platform for commercial development team of biotech, medtech and digital health startups

Milepoint: The platform for commercial development team of biotech, medtech and digital health startups
Partnerships and Growth
Member News

Learn more about the newest member to join our global community: Milepoint. It is a non-for-pfrofit platform that provides access to support the development of digital health.

Milepoint is a not-for-profit platform for commercial development teams of biotech, medtech, and digital health startups and scaleups. We offer an alternative to high-ticket consulting projects and provide access to flexible support in market validation, regulatory strategy, patient value, market access, and pricing in the EU and US markets. We are a community of independent executives and advisors with experience in top Pharma and MedTech companies, committed to helping innovators reach patients.

We operate in two complementary models. For any of the typical ongoing commercial validation needs that early-stage companies face (e.g., KOL advisory boards, patient surveys and interviews, market assessment, support with investor decks), we provide ad-hoc support through your milepoint partners and analysts. We also connect you to senior executives for longer-term projects, interim / fractional support as an extension of your team, or even full-time and co-founder roles, at conditions adjusted to your stage of development.

With ECHAlliance we aim to increase the awareness of the novel advisory model that we offer to life sciences companies and expand our network among organizations that can benefit the most – medtech clusters, technology transfer offices, and other non-profits working at the forefront of healthcare innovation.

NEWS​

Related News

Finland – Kuopio Health Ecosystem is ECHAlliance Ecosystem of the Month – July

15 Jul 2024
This month we are featuring our Finland - Kuopio Health Ecosystem as our Ecosystem of the Month.

EU JAMRAI- 2: Building a One Health World

15 Jul 2024
The mission at EU-JAMRAI 2 is to lead the fight against antimicrobial resistance (AMR) through joint and coordinated action across Europe.

Team MediBoost Wins AI4Health.Cro Innovation Competition

15 Jul 2024
Team MediBoost clinched the top prize at this year’s AI4Health.Cro innovation competition, winning €5,000 for their groundbreaking application designe...

Tackling obesity

8 Jul 2024
Apply for funding to develop effective strategies to tackle overweight and obesity. ‘Tackling obesity’ is open to applications submitted to the Popula...

Cancer research transatlantic development and skills enhancement award 2024

4 Jul 2024
Following the UK-US Cancer Summit, MRC and NIHR, in partnership with NCI, are launching a second competition for the cancer research transatlantic dev...

24/52 Liver Disease (EME Programme)

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *